SCHANTZ FLORES: Open Payments
NPI 1164054649 · MALVERN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 28 payments from 8 companies in 2025. Trend: 2023 $89 · 2024 $153 · 2025 $1,360
Travel & lodging: $847Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 16 | $1,090 |
| Neurocrine BioSciences, Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: SPRAVATO, INGREZZA, CAPLYTA, FANAPT, Auvelity, COBENFY, ABILIFY MAINTENA, TRINTELLIX.
Industry payments across AR — which companies pay providers there.
